Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Gynecol Oncol. 2021 Dec 11;164(2):428–436. doi: 10.1016/j.ygyno.2021.11.021

Figure 3:

Figure 3:

The plot lines present the patient-reported FACT/GOG-Ntx Subscale (short) scores. CP: Carboplatin/Paclitaxel (6 cycles); Cis-RT+CP: Cisplatin /RT+ CP (4 cycles). The least-squares means estimates were obtained from a fitted mixed model adjusting for pre-treatment score (baseline score) and patient’s age at the enrollment. A lager score indicates favorable or less NTX symptoms. The least squares means differences (CisRT+CP vs CP) were estimated from the fitted mixed models. The p-values for the least squares means differences were adjusted with Hochberg step-up method first for multiple time points and then adjusted with Bonferroni method for multiple measures.